Feed / Theme
Confirmed

Enterprise AI Solutions

29 names are moving together; 34% are participating in the current session.

Co-movement

Observed intraday paths are not available for this group yet.

Members

TICKERCompanySectorTodayObserved activity
XMTRXometry, Inc.Industrials+2.6%Group member
AIC3.ai, Inc.Technology-0.4%Group member
LYFTLyft, Inc.Technology-0.9%Group member
CLIKCLICK HOLDINGS LIMITEDConsumer Cyclical+1.4%Group member
EWTXEdgewise Therapeutics, Inc.Healthcare-6.1%Group member
FATEFate Therapeutics, Inc.Healthcare-0.3%Group member
AIOSAIOS Tech Inc.Technology+0.5%Group member
FRHCFreedom Holding Corp.Financial Services+2.8%Group member
NXDRNextdoor Holdings, Inc.Communication Services+0.2%Group member
GDYNGrid Dynamics Holdings, Inc.Technology-0.8%Group member
RDDTReddit, Inc.Communication Services-2.6%Group member
SEBSeaboard CorporationIndustrials+1.9%Group member
HPQHP Inc.Technology+0.3%Group member
PTONPeloton Interactive, Inc.Consumer Cyclical-1.1%Group member
BULLWebull CorporationTechnology+1.0%Group member
LIFLife360, Inc.Technology+0.3%Group member
CARAvis Budget Group, Inc.Industrials-2.1%Group member
MASK3 E Network Technology Group LtTechnology-5.8%Group member
OGNOrganon & Co.Healthcare+0.2%Most structurally connected
NMAXNewsmax, Inc.Communication Services-2.3%Group member
PALIPalisade Bio, Inc.Healthcare+0.5%Group member
VVXV2X, Inc.Industrials-0.5%Group member
APPApplovin CorporationCommunication Services-2.6%Group member
OKTAOkta, Inc.Technology-6.9%Group member

Why we believe this

Cohort

29 names

Participation

34% this session

Observed history

1 daily builds

Filing coverage

23/29 members

demand / volume affecting revenue

Outside of the U.S., sales declined due to the timing of shipments in selective emerging markets, partially offset by increased demand and access in Brazil;

OGN 10-Q

restructuring affecting expense

For the three months ended March 31, 2025, we incurred restructuring costs of $86 million, comprised primarily of headcount-related restructuring expense associated with restructuring initiatives that were aimed at driving operational efficiencies in 2025. -30- Table of Contents Interest Expense Interest expense decreased 10% for the three months ended March 31, 2026, compared to 2025, due to the repurchase and cancellation of approximately $419 million of the Company’s 5.125% notes due in 2031 (“the 2031 Notes”) during the second and fourth quarters of 2025 combined with lower reference rates on our variable rate debt.

OGN 10-Q

credit / rates affecting interest expense

Interest expense decreased 1% for the nine months ended September 30, 2025, compared to 2024, and reflects lower interest rates as a result of refinancing a portion of our long-term debt in the prior year and the repurchase and cancellation of the 2031 Notes combined with lower reference rates on our variable rate debt, offset by interest related to the debt acquired as part of the Dermavant acquisition and previously unamortized debt issuance fees of approximately $2 million associated with the repurchase and cancellation of $242 million of the 2031 Notes.

OGN 10-Q

Cross-asset confirmation is still fragile, so spillover can stall before it becomes durable.

Connected, outside the group

No high-confidence filing-linked non-members are available for this group yet.

History

Historical cohort observations are not available yet.